FDA approval summary: Sorafenib for advanced renal cell carcinoma

Authors

R. C. Kane
A. T. Farrell
H. Saber
S. Tang
G. Williams

Document Type

Journal Article

Publication Date

2006

Journal

Clinical Cancer Research

Volume

12

Issue

24

Inclusive Pages

7271-7278

Keywords

Medicine

APA Citation

Kane, R., Farrell, A., Saber, H., Tang, S., & Williams, G. (2006). FDA approval summary: Sorafenib for advanced renal cell carcinoma. Clinical Cancer Research, 12 (24). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/2533